Live Science on MSN

'Groundbreaking' gene therapy is first treatment for Huntington's disease to slow the condition

Results from a three-year trial suggest an experimental gene therapy for Huntington's disease can slow the progression of the ...
Boston Herald

Parkinson’s research: Laser light helmet therapy helped ‘improve motor function’ in patients

A new Parkinson’s disease clinical trial with patients wearing laser light helmets has shown “promising results,” as the therapy helped “improve motor function” for those facing the progressive ...

First Parkinson’s disease patient treated in BlueRock’s pivotal Phase III trial of investigational cell therapy bemdaneprocel

PDite-2 is the first Phase III pivotal clinical trial for an investigational allogeneic pluripotent stem cell derived therapy ...
University of Delaware

How pain impacts motor learning

Susanne Morton has spent more than two decades studying motor learning. Morton is an associate professor in the Department of Physical Therapy (PT) at the University of Delaware’s College of Health ...

Experimental gene therapy found to slow Huntington’s disease progression, company says

An experimental gene therapy was found to slow the progression of Huntington’s disease in a “pivotal” study, according to ...
PharmaTimes

First patient treated in pivotal trial of Parkinson’s cell therapy

BlueRock Therapeutics has dosed the first patient in its pivotal phase 3 trial of bemdaneprocel, an investigational cell ...
Hosted on MSN

Gene therapy protects against motor neuron disease in rats

University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success using a gene therapy treatment in an animal model. The approach, which uses ...